(Q35106670)

6 August 2017

1 reference

title

Genetic counseling for prostate cancer risk (English)

1 reference

6 August 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12694223

23 December 2023

1 reference

https://api.crossref.org/works/10.1034/J.1399-0004.2003.00038.X

23 December 2023

author name string

Zeegers MP

3

1 reference

6 August 2017

A. M. Nieder

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12694223

23 December 2023

S. S. Taneja

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12694223

23 December 2023

M. P A. Zeegers

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12694223

23 December 2023

H. Ostrer

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12694223

23 December 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12694223

23 December 2023

publication date

1 March 2003

1 reference

full work available at URL

6 August 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1034%2Fj.1399-0004.2003.00038.x

1 reference

https://api.crossref.org/works/10.1034/J.1399-0004.2003.00038.X

https://onlinelibrary.wiley.com/doi/pdf/10.1034/j.1399-0004.2003.00038.x

23 December 2023

1 reference

https://api.crossref.org/works/10.1034/J.1399-0004.2003.00038.X

23 December 2023

1 reference

6 August 2017

volume

63

1 reference

6 August 2017

issue

3

1 reference

6 August 2017

page(s)

169-176

1 reference

Family history and prostate cancer risk

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2003.00038.X

Familial prostate cancer: outcome following radiation therapy with or without adjuvant androgen ablation

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2003.00038.X

Absence of 185delAG mutation of the BRCA1 gene and 6174delT mutation of the BRCA2 gene in Ashkenazi Jewish men with prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2003.00038.X

Prostate cancer mortality after introduction of prostate-specific antigen mass screening in the Federal State of Tyrol, Austria

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2003.00038.X

Segregation analysis of prostate cancer in Sweden: support for dominant inheritance

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2003.00038.X

inferred from DOI database lookup

7 January 2021

based on heuristic

No difference in survival between sporadic, familial and hereditary prostate cancer

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2003.00038.X

inferred from DOI database lookup

7 January 2021

based on heuristic

Familial prostate cancer studies in Utah

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2003.00038.X

inferred from DOI database lookup

7 January 2021

based on heuristic

Cancer statistics, 2002

1

1 reference

https://api.crossref.org/works/10.1034/J.1399-0004.2003.00038.X

Studies of genetic factors in prostate cancer in a twin population

23 December 2023

2

1 reference

https://api.crossref.org/works/10.1034/J.1399-0004.2003.00038.X

Heredity and prostate cancer: a study of World War II veteran twins

23 December 2023

3

1 reference

https://api.crossref.org/works/10.1034/J.1399-0004.2003.00038.X

Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland

23 December 2023

4

1 reference

https://api.crossref.org/works/10.1034/J.1399-0004.2003.00038.X

Familial aggregation of prostate cancer management while waiting for the identification of hereditary prostate cancer genes

23 December 2023

6

1 reference

https://api.crossref.org/works/10.1034/J.1399-0004.2003.00038.X

Family history and the risk of prostate cancer

23 December 2023

7

1 reference

https://api.crossref.org/works/10.1034/J.1399-0004.2003.00038.X

African American men and hereditary/familial prostate cancer: Intermediate-risk populations for chemoprevention trials

23 December 2023

10

1 reference

https://api.crossref.org/works/10.1034/J.1399-0004.2003.00038.X

Familial study of prostate cancer in Jamaica

23 December 2023

11

1 reference

https://api.crossref.org/works/10.1034/J.1399-0004.2003.00038.X

Risk of Cancer in Relatives of Prostate Cancer Probands

23 December 2023

12

1 reference

https://api.crossref.org/works/10.1034/J.1399-0004.2003.00038.X

Family history and prostate cancer risk in black, white, and Asian men in the United States and Canada

23 December 2023

14

1 reference

https://api.crossref.org/works/10.1034/J.1399-0004.2003.00038.X

Familial prostate cancer in Sweden. A nationwide register cohort study

23 December 2023

15

1 reference

https://api.crossref.org/works/10.1034/J.1399-0004.2003.00038.X

Familial aspects of prostate cancer: a case control study

23 December 2023

16

1 reference

https://api.crossref.org/works/10.1034/J.1399-0004.2003.00038.X

Evidence of an X-linked or recessive genetic component to prostate cancer risk

23 December 2023

17

1 reference

https://api.crossref.org/works/10.1034/J.1399-0004.2003.00038.X

Familiality of cancer in Utah

23 December 2023

18

1 reference

https://api.crossref.org/works/10.1034/J.1399-0004.2003.00038.X

Family history of prostate cancer: A multi-center case-control study in Canada

23 December 2023

21

1 reference

https://api.crossref.org/works/10.1034/J.1399-0004.2003.00038.X

The risk of malignant tumours in first-degree relatives of men with early onset prostate cancer: a population-based cohort study

23 December 2023

22

1 reference

https://api.crossref.org/works/10.1034/J.1399-0004.2003.00038.X

Prostate cancer risk in U.S. blacks and whites with a family history of cancer

23 December 2023

23

1 reference

https://api.crossref.org/works/10.1034/J.1399-0004.2003.00038.X

Mendelian inheritance of familial prostate cancer

23 December 2023

25

1 reference

https://api.crossref.org/works/10.1034/J.1399-0004.2003.00038.X

Early-onset hereditary prostate cancer is not associated with specific clinical and biological features

23 December 2023

27

1 reference

https://api.crossref.org/works/10.1034/J.1399-0004.2003.00038.X

Significance of familial history of prostate cancer to traditional prognostic variables, genetic biomarkers, and recurrence after radical prostatectomy

23 December 2023

31

1 reference

https://api.crossref.org/works/10.1034/J.1399-0004.2003.00038.X

Biochemical recurrence after radical prostatectomy in black and white American men with a positive or negative family history of prostate cancer

23 December 2023

32

1 reference

https://api.crossref.org/works/10.1034/J.1399-0004.2003.00038.X

Characteristics of prostate cancer in families potentially linked to the hereditary prostate cancer 1 (HPC1) locus

23 December 2023

34

1 reference

https://api.crossref.org/works/10.1034/J.1399-0004.2003.00038.X

CORRELATES OF DISSATISFACTION WITH TREATMENT IN PATIENTS WITH PROSTATE CANCER DIAGNOSED THROUGH SCREENING

23 December 2023

36

1 reference

https://api.crossref.org/works/10.1034/J.1399-0004.2003.00038.X

Should the age specific prostate specific antigen cutoff for prostate biopsy be higher for black than for white men older than 50 years?

23 December 2023

37

1 reference

https://api.crossref.org/works/10.1034/J.1399-0004.2003.00038.X

Racial differences in prostate carcinogenesis. Histologic and clinical observations

23 December 2023

38

1 reference

https://api.crossref.org/works/10.1034/J.1399-0004.2003.00038.X

Disease-free survival difference between African Americans and whites after radical prostatectomy for local prostate cancer: a multivariable analysis

23 December 2023

39

1 reference

https://api.crossref.org/works/10.1034/J.1399-0004.2003.00038.X

Systematic Population-Based Assessment of Cancer Risk in First-Degree Relatives of Cancer Probands

23 December 2023

41

1 reference

https://api.crossref.org/works/10.1034/J.1399-0004.2003.00038.X

Cancer risk in families with hereditary prostate carcinoma

23 December 2023

43

1 reference

https://api.crossref.org/works/10.1034/J.1399-0004.2003.00038.X

Evidence for a rare prostate cancer-susceptibility locus at chromosome 1p36.

23 December 2023

44

1 reference

https://api.crossref.org/works/10.1034/J.1399-0004.2003.00038.X

No evidence for a role of BRCA1 or BRCA2 mutations in Ashkenazi Jewish families with hereditary prostate cancer

23 December 2023

46

1 reference

https://api.crossref.org/works/10.1034/J.1399-0004.2003.00038.X

Common mutations in BRCA1 and BRCA2 do not contribute to early prostate cancer in Jewish men.

23 December 2023

47

1 reference

https://api.crossref.org/works/10.1034/J.1399-0004.2003.00038.X

The Jewish Ashkenazi founder mutations in the BRCA1/BRCA2 genes are not found at an increased frequency in Ashkenazi patients with prostate cancer

23 December 2023

48

1 reference

https://api.crossref.org/works/10.1034/J.1399-0004.2003.00038.X

Familial cancer risks in offspring from discordant parental cancers

23 December 2023

49

1 reference

https://api.crossref.org/works/10.1034/J.1399-0004.2003.00038.X

Major susceptibility locus for prostate cancer on chromosome 1 suggested by a genome-wide search

23 December 2023

51

1 reference

https://api.crossref.org/works/10.1034/J.1399-0004.2003.00038.X

Predisposing gene for early-onset prostate cancer, localized on chromosome 1q42.2-43

23 December 2023

52

1 reference

https://api.crossref.org/works/10.1034/J.1399-0004.2003.00038.X

Evidence for a prostate cancer susceptibility locus on the X chromosome.

23 December 2023

53

1 reference

https://api.crossref.org/works/10.1034/J.1399-0004.2003.00038.X

A candidate prostate cancer susceptibility gene at chromosome 17p

23 December 2023

54

1 reference

https://api.crossref.org/works/10.1034/J.1399-0004.2003.00038.X

Evidence for a prostate cancer-susceptibility locus on chromosome 20.

23 December 2023

55

1 reference

https://api.crossref.org/works/10.1034/J.1399-0004.2003.00038.X

Genetics of prostate cancer: too many loci, too few genes

23 December 2023

57

1 reference

https://api.crossref.org/works/10.1034/J.1399-0004.2003.00038.X

Germline mutations in the ribonuclease L gene in families showing linkage with HPC1

23 December 2023

58

1 reference

https://api.crossref.org/works/10.1034/J.1399-0004.2003.00038.X

Germline mutations and sequence variants of the macrophage scavenger receptor 1 gene are associated with prostate cancer risk

23 December 2023

59

1 reference

https://api.crossref.org/works/10.1034/J.1399-0004.2003.00038.X

Germline alterations of the RNASEL gene, a candidate HPC1 gene at 1q25, in patients and families with prostate cancer

23 December 2023

60

1 reference

https://api.crossref.org/works/10.1034/J.1399-0004.2003.00038.X

Role of HPC2/ELAC2 in hereditary prostate cancer

23 December 2023

61

1 reference

https://api.crossref.org/works/10.1034/J.1399-0004.2003.00038.X

ELAC2/HPC2 involvement in hereditary and sporadic prostate cancer

23 December 2023

62

1 reference

https://api.crossref.org/works/10.1034/J.1399-0004.2003.00038.X

Association of HPC2/ELAC2 genotypes and prostate cancer.

23 December 2023

63

1 reference

https://api.crossref.org/works/10.1034/J.1399-0004.2003.00038.X

Evaluation of linkage and association of HPC2/ELAC2 in patients with familial or sporadic prostate cancer

23 December 2023

65

1 reference

https://api.crossref.org/works/10.1034/J.1399-0004.2003.00038.X

HPC2 variants and screen-detected prostate cancer

23 December 2023

66

1 reference

https://api.crossref.org/works/10.1034/J.1399-0004.2003.00038.X

Analysis of the RNASEL gene in familial and sporadic prostate cancer

23 December 2023

67

1 reference

https://api.crossref.org/works/10.1034/J.1399-0004.2003.00038.X

A novel founder mutation in the RNASEL gene, 471delAAAG, is associated with prostate cancer in Ashkenazi Jews

23 December 2023

68

1 reference

https://api.crossref.org/works/10.1034/J.1399-0004.2003.00038.X

Polymorphic repeats in the androgen receptor gene: molecular markers of prostate cancer risk

23 December 2023

69

1 reference

https://api.crossref.org/works/10.1034/J.1399-0004.2003.00038.X

The CAG repeat within the androgen receptor gene and its relationship to prostate cancer

23 December 2023

70

1 reference

https://api.crossref.org/works/10.1034/J.1399-0004.2003.00038.X

Association of prostate cancer risk with genetic polymorphisms in vitamin D receptor and androgen receptor

23 December 2023

72

1 reference

https://api.crossref.org/works/10.1034/J.1399-0004.2003.00038.X

Racial variation in prostate cancer incidence and in hormonal system markers among male health professionals

23 December 2023

73

1 reference

https://api.crossref.org/works/10.1034/J.1399-0004.2003.00038.X

Polymorphic repeats in the androgen receptor gene in high-risk sibships

23 December 2023

74

1 reference

https://api.crossref.org/works/10.1034/J.1399-0004.2003.00038.X

Prostate-specific antigen best practice policy--part I: early detection and diagnosis of prostate cancer

23 December 2023

75

1 reference

https://api.crossref.org/works/10.1034/J.1399-0004.2003.00038.X

American Cancer Society guidelines for the early detection of cancer

23 December 2023

76

1 reference

https://api.crossref.org/works/10.1034/J.1399-0004.2003.00038.X

Screening decreases prostate cancer death: first analysis of the 1988 Quebec prospective randomized controlled trial

23 December 2023

79

1 reference

https://api.crossref.org/works/10.1034/J.1399-0004.2003.00038.X

Two consecutive sets of transrectal ultrasound guided sextant biopsies of the prostate for the detection of prostate cancer

23 December 2023

81

1 reference

https://api.crossref.org/works/10.1034/J.1399-0004.2003.00038.X

Detection of Organ-Confined Prostate Cancer Is Increased Through Prostate-Specific Antigen—Based Screening

23 December 2023

82

1 reference

https://api.crossref.org/works/10.1034/J.1399-0004.2003.00038.X

Prostate Cancer Detection in a Clinical Urological Practice by Ultrasonography, Digital Rectal Examination and Prostate Specific Antigen

23 December 2023

83

1 reference

https://api.crossref.org/works/10.1034/J.1399-0004.2003.00038.X

The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial of the National Cancer Institute: history, organization, and status

23 December 2023

85

1 reference

https://api.crossref.org/works/10.1034/J.1399-0004.2003.00038.X

Men's attitudes regarding genetic testing for hereditary prostate cancer risk.

23 December 2023

86

1 reference

https://api.crossref.org/works/10.1034/J.1399-0004.2003.00038.X

Knowledge and beliefs among brothers and sons of men with prostate cancer

23 December 2023

87

1 reference

https://api.crossref.org/works/10.1034/J.1399-0004.2003.00038.X

How men view genetic testing for prostate cancer risk: findings from focus groups

23 December 2023

88

1 reference

https://api.crossref.org/works/10.1034/J.1399-0004.2003.00038.X

23 December 2023

Identifiers

1 reference

6 August 2017

1 reference